Friday, March 27, 2020

FDA greenlights first 45-minute, point-of-care coronavirus diagnostic test Saturday, March 21, 2020

FDA greenlights first 45-minute, point-of-care coronavirus diagnostic test

Saturday, March 21, 2020
The FDA has authorized its first rapid, point-of-care diagnostic for the novel coronavirus—allowing physicians in hospitals, clinics and emergency rooms to test a sample for the disease in about 45 minutes.

Biopharma's no-holds-barred fight to find a COVID-19 vaccine: The full list Friday, March 20, 2020

Biopharma's no-holds-barred fight to find a COVID-19 vaccine: The full list

Friday, March 20, 2020
The hunt is well underway for medicines to combat COVID-19, but it will be longer for vaccines than it will be for drug treatments. Here’s a guide to the 35 vaccines in development against COVID-19, including Moderna Therapeutics' phase 1 RNA shot, Pfizer and BioNTech's candidate hard on its heels and a host of preclinical prospects.

Top COVID-19 aspirants chloroquine, AbbVie's Kaletra and a flu drug disappoint in clinical tests Tuesday, March 24, 2020

Top COVID-19 aspirants chloroquine, AbbVie's Kaletra and a flu drug disappoint in clinical tests

Tuesday, March 24, 2020
Malaria drug chloroquine, AbbVie’s HIV combo therapy Kaletra and an influenza med called Arbidol are among top candidates that physicians are repurposing for the treatment of COVID-19. Despite backing from officials, though, the three have disappointed separately in two clinical trials in mild Chinese patients.

Biopharma's leading treatment hopes against COVID-19 Friday, March 20, 2020

Biopharma's leading treatment hopes against COVID-19

Friday, March 20, 2020
As the biotech industry tries to match the pace of the COVID-19 pandemic with its own research response, we at FierceBiotech are rounding up the industry’s attempts to combat the virus after infection.

Novartis, Mylan and Teva to supply tens of millions of chloroquine tablets to fight COVID-19 Friday, March 20, 2020

Novartis, Mylan and Teva to supply tens of millions of chloroquine tablets to fight COVID-19

Friday, March 20, 2020
As efforts to discover new COVID-19 medicines roll on, President Donald Trump and others this week focused attention on the decades-old malaria drug chloroquine. Bayer got things rolling with an initial donation of the drug, and now Novartis, Mylan and Teva are taking steps to deliver tens of millions of tablets

Tuesday, March 24, 2020

Texas' lieutenant governor suggests grandparents are willing to die for US economy Adrianna Rodriguez, USA TODAY 8 hrs ago

https://www.msn.com/en-us/news/us/texas-lieutenant-governor-suggests-grandparents-are-willing-to-die-for-us-economy/ar-BB11DvoL

NYC doc details harrowing day in local ER: ‘I survived Ebola. I fear COVID-19’ Nancy Dillon 5 hrs ago

https://www.msn.com/en-us/news/us/nyc-doc-details-harrowing-day-in-local-er-i-survived-ebola-i-fear-covid-19/ar-BB11EoNu

Trump versus the scientists: The president’s tug-of-war with experts over coronavirus policy Ashley Parker,, Josh Dawsey, Yasmeen Abutaleb 28 mins ago

https://www.msn.com/en-us/news/politics/trump-versus-the-scientists-the-presidents-tug-of-war-with-experts-over-coronavirus-policy/ar-BB11EPqC